Peter L. Hoang
Sr. VP of Bus. Development, BELLICUM PHARMACEUTICALS, INC.
Companies
- Marker Therapeutics, Inc.Board member Sep 25, 2017 to Mar 28, 20221
- Marker Therapeutics, Inc.Chief executive officer Sep 25, 2017 to Mar 28, 20221
- Marker Therapeutics, Inc.President Sep 25, 2017 to Mar 28, 20221
- BELLICUM PHARMACEUTICALS, INCSr. VP of Bus. Development Dec 17, 2014 to Jan 5, 20172
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Marker Therapeutics, Inc. MRKR483,286 shares3$444.6K at $0.92Mar 24, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 24, 2022Shares withheld for tax 48,376 shares at $0.48 of Marker Therapeutics, Inc.3
- Mar 24, 2022Granted 199,094 shares of Marker Therapeutics, Inc.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3